Evidence map›Paper›PMID 36660027›Full record

ArticleMolecular syndromology2023

SLC26A2/DTDST Spectrum: A Cohort of 12 Patients Associated with a Comprehensive Review of the Genotype-Phenotype Correlation.

Cynthia Silveira, Karina da Costa Silveira, Maria D Lacarrubba-Flores, Maurício T Sakata, Silvia N Carbognani, Juan Llerena, Carolina A Moreno, Denise P Cavalcanti

Open access · greenAbstract read
In one paragraph

Article in Molecular syndromology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Cynthia SilveiraSkeletal Dysplasia Group, Department of Translational Medicine, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
Karina da Costa SilveiraSkeletal Dysplasia Group, Department of Translational Medicine, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
Maria D Lacarrubba-FloresSkeletal Dysplasia Group, Department of Translational Medicine, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
Maurício T SakataSkeletal Dysplasia Group, Department of Translational Medicine, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
Silvia N CarbognaniMaternidad Oroño, Rosario, Argentina.
Juan LlerenaCentro de Genética Médica & Centro de Referência para Doenças Raras, IFF/Fiocruz, Rio de Janeiro, Brazil.
Carolina A MorenoPerinatal Genetic Program, Department of Translational Medicine, University of Campinas, Campinas, Brazil.
Denise P CavalcantiSkeletal Dysplasia Group, Department of Translational Medicine, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
Universidade Estadual de Campinas (UNICAMP) · BRCentro Científico Tecnólogico - Rosario · ARNational Institute on Population Medical Genetics · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Pathogenic variants in the Methods: The local patients were genotyped by Sanger sequencing or next-generation sequencing (NGS). We reviewed data from the literature regarding phenotype, zygosity, and genotype in parallel. Results: The local cohort enrolled 12 patients, including one with a Desbuquois-like phenotype. All but one showed biallelic mutations, however, only one allele mutated in a fetus presenting ACG1B was identified. The literature review identified 42 articles and the analyses of genotype and zygosity included the 12 local patients. Discussion: The R279W variant was the most prevalent among the local patients. It was in homozygosity (hmz) in 2 patients with rMED and in compound heterozygosity (chtz) in 9 patients. The genotype and zygosity review of all patients led to the following conclusions: DTD is the most common phenotype in Finland due to a Finnish mutation (c.727-1G>C). Outside of Finland, rMED is the most prevalent phenotype, usually associated with R279W in hmz. In contrast, DTD's genotype is usually in chtz. Despite a large number of variants (38), just 8 are recurrent (R279W, C653S, c.-26+2T>C, R178*, K575Sfs*10, V340del, G663R, T512K). The last 3 in hmz lead to lethal phenotypes. The Finnish mutation is found only in chtz outside of Finland, being associated with all 4 classical phenotypes. The p.R178* and p.K575Sfs*10 variants should be viewed as lethal mutations since both were mainly described with lethal phenotypes and were never reported in hmz. The existence of 9 patients with only one mutated allele suggests that other mutations in the other allele of these patients still need to be unveiled.

Indexed as

ACG1BAO2Diastrophic dysplasiarMEDSLC26A2/DTDSTSwedish key proximal femur

Identifiers

PMID36660027
PMCPMC9843583
OpenAlexW4282933075

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.